Home
>
US Stocks
>
Beam Therapeutics Inc
Beam Therapeutics Inc
BEAM

Beam Therapeutics Inc (BEAM)

$94.580.9%

  • $

1D

1W

1M

1Y

3Y

5Y

Key Stats

Open$96.45
Today Low/High$94.23 / $97.97
52 Week Low/High$33 / $138.52
P/E ratio-13.5
Market Cap$6.38B

Company Details

Beam Therapeutics is a biotechnology company committed to establishing the leading, fully integrated platform for precision genetic medicines. To achieve this vision, Beam has assembled a platform that includes a suite of gene editing and delivery technologies and is in the process of building internal manufacturing capabilities. Beam's suite of gene editing technologies is anchored by base editing, a proprietary technology that enables precise, predictable and efficient single base changes, at targeted genomic sequences, without making double-stranded breaks in the DNA. This enables a wide range of potential therapeutic editing strategies that Beam is using to advance a diversified portfolio of base editing programs. Beam is a values-driven organization committed to its people, cutting-edge science, and a vision of providing life-long cures to patients suffering from serious diseases.
OrganisationBeam Therapeutics Inc
Employees181
IndustryHealth Technology

Discover more

Frequently Asked Questions

What is Beam Therapeutics Inc (BEAM) share price today?

Can Indians buy Beam Therapeutics Inc (BEAM) shares?

How can I buy Beam Therapeutics Inc (BEAM) shares from India?

Can Fractional shares of Beam Therapeutics Inc (BEAM) be purchased?

What are the documents required to start investing in Beam Therapeutics Inc (BEAM) stocks?

We are a SEBI registered investement advisor